Publication number: 20150023792
Abstract: The invention relates to a wind turbine rotor blade heating process with a wind turbine rotor blade de-icing system arranged on a rotor blade (11), including modular heating elements (210, 211, 212, 213, 214, 220, 221, 222, 223, 230, 231, 232, 24) driven cyclically, recurring, intermittently and/or continuously, wherein at least one modular heating element (210, 211, 212, 213, 214, 220, 221, 222, 223, 230, 231, 232, 24) is provided with a temperature sensor and/or an electric resistance measuring sensor, with which a continuous measurement of the environment measurement values (U) is carried out and the wind turbine rotor blade de-icing system is activated upon reaching predetermined environmental measurement values (U), wherein upon reaching predetermined environment conditions (U), first, a measurement cycle is started, wherein a modular heating element (210, 211, 212, 213, 214, 220, 221, 222, 223, 230, 231, 232, 24) is driven, of which the temperature profile (f=dt (t)) is measured and compared with a heat
Type:
Application
Filed:
July 16, 2014
Publication date:
January 22, 2015
Inventors:
Joerg Spitzner, Fabian Timmo Seebo, Robert Mitschke, Ramon Bhatia, Alexander Backs
Patent number: 8084457
Abstract: The present invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, and pharmaceutical compositions containing at least one of said 4,6-di substituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof.
Type:
Grant
Filed:
September 15, 2004
Date of Patent:
December 27, 2011
Assignees:
Lead Discovery Center GmbH, Bayer Pharma AG
Inventors:
Axel Choidas, Alexander Backes, Matt Cotten, Ola Engkvist, Beatrice Felber, Achim Freisleben, Klaus Godl, Zoltán Greff, Peter Habenberger, Doris Hafenbradl, Christian Hartung, Thomas Herget, Edmund Hoppe, Bert Klebl, Andrea Missio, Gerhard Müller, Wilfried Schwab, Birgit Zech, Jose Bravo, John Harris, Joelle Le, Jackie Macritchie, Vladimir Savic, Brad Sherborne, Don Simpson
Publication number: 20070275962
Abstract: Described are heterobicyclic compounds such as 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]thiopyran 3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid amides, or benzo[b]thiophene-3-carboxylic acid amides and pharmaceutically acceptable salts thereof, the use of these derivatives for the prophylaxis and/or treatment of various diseases such as infectious diseases, including mycobacteriainduced infections and opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, as well as compositions containing at least one heterobicyclic compound and/or pharmaceutically acceptable salts thereof. Furthermore, reaction procedures for the synthesis of the heterobicyclic compound are disclosed.
Type:
Application
Filed:
September 10, 2004
Publication date:
November 29, 2007
Applicant:
GPC BIOTECH AG
Inventors:
Anil Koul, Bert Klebl, Gerhard Muller, Andrea Missio, Wilfried Schwab, Doris Hafenbradl, Lars Neumann, Marc-Nicola Sommer, Stefan Muller, Edmund Hoppe, Achim Freisleben, Alexander Backes, Christian Hartung, Beatrice Felber, Birgit Zech, Ola Engkvist, Gyorgy Keri, Laszlo Orfi, Peter Banhegyi, Zoltan Greff, Zoltan Horvath, Zoltan Varga, Peter Marko, Janos Pato, Istvan Szabadkai, Zsolt Szekelyhid, Frigyes Waczek
Publication number: 20070191344
Abstract: The present invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, and pharmaceutical compositions containing at least one of said 4,6-di substituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof.
Type:
Application
Filed:
September 15, 2004
Publication date:
August 16, 2007
Inventors:
Axel Choidas, Alexander Backes, Matt Cotten, Ola Engkvist, Beatrice Felber, Achim Freisleben, Klaus Godl, Zoltan Greff, Peter Habenberger, Doris Hafenbradl, Christian Hartung, Thomas Herget, Edmund Hoppe, Bert Klebl, Andrea Missio, Gerhard Muller, Wilfried Schwab, Birgit Zech, Jose Bravo, John Harris, Joelle Le, Jackie Macritchie, Vladimir Savic, Brad Sherborne, Don Simpson